Evidence map›Paper›PMID 30926772›Full record

ReviewCell death & disease2019

Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases.

Yuyi Han, Qianwen Shang, Jin Yao, Yong Ji

Open access · goldAbstract readReview
In one paragraph

Review in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Recent Advances in Molecular Research on Hydrogen Sulfide (HInternational journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Article
  4. Article
  5. HBiochemistry · 2026
    Article
  6. Review
  7. Review
  8. HFrontiers in cell and developmental biology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Signaling Paradigms of HAntioxidants (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Article
  15. Pills of Multi-Target HInternational journal of molecular sciences · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Yuyi HanDepartment of Ophthalmology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, China.
Qianwen ShangInstitutes for Translational Medicine, Soochow University Medical College, Suzhou, China.
Jin YaoThe Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China. njmudryao@hotmail.com.
Yong JiKey Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China. yongji@njmu.edu.cn.
Nanjing Medical University · CNSecond Affiliated Hospital of Nanjing Medical University · CNSecond Hospital of Shanxi Medical University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen sulfide (H

Indexed as

AnimalsBlood-Retinal BarrierCyclic AMPDiabetic RetinopathyGlaucomaGlycation End Products, AdvancedHumansHydrogen SulfideIntraocular PressureOxidative StressRetinal DegenerationRetinal NeuronsRetinal Pigment EpitheliumStem Cell TransplantationCyclic AMPGlycation End Products, AdvancedHydrogen Sulfide

Identifiers

PMID30926772
PMCPMC6441042
OpenAlexW2927269321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.